Email this article to a friend
Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
-
* Corresponding author: Robert J Brogan robbie.brogan@googlemail.com
Pediatric Rheumatology 2009, 7:3 doi:10.1186/1546-0096-7-3